Publications by authors named "M Haeberer"
Respiratory syncytial virus (RSV) is increasingly a recognized cause of severe respiratory infection among adults. This retrospective observational study compared the costs of RSV and influenza hospitalizations in adults aged ≥18 years admitted to the Spanish National Healthcare System between 2016 and 2019. Mean costs per hospitalization episode were compared using a multivariable log-gamma generalized linear model adjusted by age, risk group and calendar year.
View Article and Find Full Text PDFThis retrospective observational study aimed to quantify the costs associated with hospitalized respiratory syncytial virus (RSV) in children <18 years admitted to the Spanish National Healthcare System between 2016 and 2019 and contrast them with the costs of unspecified bronchiolitis/bronchitis/pneumonia (UBP) and influenza. The mean cost per hospitalization episode was reported by age group, risk category and prematurity. Total annual hospitalization costs were calculated from population incidence rates and the mean cost per episode.
View Article and Find Full Text PDFArticle Synopsis
- The study focused on analyzing RSV infection risks in children under 24 months in Valladolid from 2010 to 2022, comparing these risks with those of influenza and COVID-19.
- It involved a retrospective cohort study of 1,507 RSV cases, revealing that hospitalized RSV patients were generally younger and had lower comorbidity rates than those with influenza or COVID-19.
- Key findings indicated that factors like prematurity, maternal smoking, and coinfection increased the risk of severe RSV outcomes, while breastfeeding and complete vaccination were protective against hospitalization and severity.
Introduction: We aimed to describe the risk profile of respiratory syncytial virus (RSV) infections among adults ≥ 60 years in Valladolid from January 2010 to August 2022, and to compare them with influenza and COVID-19 controls.
Methods: This was a retrospective cohort study of all laboratory-confirmed RSV infections identified in centralized microbiology database during a 12-year period. We analyzed risk factors for RSV hospitalization and severity (length of stay, intensive care unit admission, in-hospital death or readmission < 30 days) and compared severity between RSV patients vs.
Introduction: Respiratory syncytial virus (RSV) causes a substantial disease burden among infants. In older children and adults, incidence is underestimated due to nonspecific symptoms and limited standard-of-care testing. We aimed to estimate RSV-attributable hospitalizations and deaths in Spain during 2016-2019.
View Article and Find Full Text PDF